...
首页> 外文期刊>Journal of perinatology: Official journal of the California Perinatal Association >NICU medication errors: identifying a risk profile for medication errors in the neonatal intensive care unit.
【24h】

NICU medication errors: identifying a risk profile for medication errors in the neonatal intensive care unit.

机译:重症监护病房(NICU)用药错误:确定新生儿重症监护病房用药错误的风险状况。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To identify a risk profile for harmful medication errors in the neonatal intensive care unit (NICU). STUDY DESIGN: A retrospective cross-sectional study on NICU medication error reports submitted to MEDMARX between 1 January 1999, and 31 December 2005. The Rao-Scott modified chi(2) test was used for analysis. RESULT: 6749 NICU medication error reports were submitted by 163 health-care facilities. Administering errors accounted for approximately one half of errors, and human factors were the most frequently cited cause of error. Patient age was not associated with an increased likelihood of an error being harmful (P=0.11). Error reports involving Institute for Safe Medication Practices (ISMP) High-Alert Medications, occurring in the prescribing phase of medication processing, or involving equipment/delivery device failures were more likely to be harmful (P< or =0.05). CONCLUSION: Risk factors for harmful medication error reports include use of ISMP High-Alert Medications, the prescribing phase of the medication use process, and failure of equipment/delivery devices.
机译:目的:确定新生儿重症监护病房(NICU)中有害用药错误的风险状况。研究设计:1999年1月1日至2005年12月31日之间提交给MEDMARX的NICU药物错误报告的回顾性横断面研究。采用Rao-Scott改良的chi(2)检验进行分析。结果:163家医疗机构提交了6749份NICU用药错误报告。管理错误约占错误的一半,人为因素是最常引用的错误原因。患者年龄与错误有害的可能性增加无关(P = 0.11)。在药物处理的处方阶段发生的涉及安全用药实践研究所(ISMP)高警惕药物的错误报告,或涉及设备/输送装置故障的错误报告更有可能是有害的(P <或= 0.05)。结论:有害药物错误报告的风险因素包括使用ISMP高警报药物,药物使用过程的处方阶段以及设备/输送设备故障。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号